Draft Appeals Guidance Does Not Address Industry’s Main Concerns, Says Device Attorney
This article was originally published in The Gray Sheet
Executive Summary
FDA’s new draft guidance explains the various routes to appeal a CDRH decision, but doesn’t do much to reform the appeals process, according to one device attorney.